Dabigatran versus warfarin in patients with atrial fibrillation
Version 2 2024-06-12, 15:39Version 2 2024-06-12, 15:39
Version 1 2021-10-20, 16:24Version 1 2021-10-20, 16:24
journal contribution
posted on 2024-06-12, 15:39authored bySJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, J Pogue, PA Reilly, E Themeles, J Varrone, S Wang, M Alings, D Xavier, J Zhu, R Diaz, BS Lewis, H Darius, HC Diener, CD Joyner, L Wallentin, AMW Alings, JV Amerena, A Avezum, I Baumgartner, J Brugada, A Budaj, V Caicedo, L Ceremuzynski, JH Chen, PJ Commerford, AL Dans, G Di Pasquale, C Erol, J Ferreira, GC Flaker, MD Flather, MG Franzosi, R Gamboa, SP Golitsyn, JA Gonzalez Hermosillo, D Halon, H Heidbuchel, SH Hohnloser, M Hori, K Huber, P Jansky, G Kamensky, M Keltai, S Kim, CP Lau, JYF Le Heuzey, LS Liu, J Nanas, PS Pais, AN Parkhomenko, KE Pedersen, LS Piegas, D Raev, O Razali, TA Simmers, PJ Smith, M Talajic, RS Tan, S Tanomsup, L Toivonen, D Vinereanu
Dabigatran versus warfarin in patients with atrial fibrillation